13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 22 holding rows worth $745,482,000.
- Accession
- 0001085146-16-003186
- Filer
- CIK 1544773
- Filed
- 2016-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, 22 entries on the cover page, a total value of $745,482,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $745,482,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 1,406,137 | $124,682,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 2,568,684 | $73,541,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,849,396 | $72,515,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 5,498,712 | $72,198,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 1,893,756 | $70,656,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 3,460,323 | $66,750,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 760,000 | $56,719,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 1,316,700 | $52,826,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 778,000 | $46,089,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 946,489 | $42,710,000 | thousands by filing date | |
| OSIRIS THERAPEUTICS INC NEW | 68827R108 | COM | 2,240,709 | $23,259,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 1,093,696 | $10,182,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,060,017 | $8,554,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 2,888,942 | $7,078,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,352,940 | $6,071,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 937,516 | $4,284,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 147,723 | $2,538,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 406,351 | $2,032,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 165,825 | $1,194,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,096,092 | $922,000 | thousands by filing date | |
| CTI BIOPHARMA CORP COM NEW | 12648L106 | Stock | 510,000 | $635,000 | thousands by filing date | |
| MERUS LABS INTL INC NEW | 59047R101 | COM | 28,484 | $47,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-16-003186 | this filing | 2016-02-16 | acceptance time not in the bulk data set |